| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phenanthrene-9,10-epoxide hydrolase activity | 1.58e-06 | 3 | 15 | 2 | GO:0019119 | |
| GeneOntologyMolecularFunction | phenanthrene-epoxide hydrolase activity | 1.58e-06 | 3 | 15 | 2 | GO:0019118 | |
| GeneOntologyMolecularFunction | epoxide hydrolase activity | 2.89e-05 | 11 | 15 | 2 | GO:0004301 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ether bonds | 4.09e-05 | 13 | 15 | 2 | GO:0016801 | |
| GeneOntologyMolecularFunction | ether hydrolase activity | 4.09e-05 | 13 | 15 | 2 | GO:0016803 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 4.77e-05 | 14 | 15 | 2 | GO:0004032 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 1.83e-04 | 27 | 15 | 2 | GO:0008106 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 2.58e-04 | 32 | 15 | 2 | GO:0004033 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 3.52e-03 | 884 | 15 | 4 | GO:0004930 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 3.99e-03 | 127 | 15 | 2 | GO:0016616 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 4.69e-03 | 138 | 15 | 2 | GO:0016614 | |
| HumanPheno | Recurrent infection of the gastrointestinal tract | 6.01e-05 | 40 | 2 | 2 | HP:0004798 | |
| HumanPheno | Autoimmune hemolytic anemia | 7.63e-05 | 45 | 2 | 2 | HP:0001890 | |
| HumanPheno | Autoimmune thrombocytopenia | 9.07e-05 | 49 | 2 | 2 | HP:0001973 | |
| HumanPheno | Colitis | 2.14e-04 | 75 | 2 | 2 | HP:0002583 | |
| HumanPheno | Inflammation of the large intestine | 5.41e-04 | 119 | 2 | 2 | HP:0002037 | |
| HumanPheno | Decreased circulating IgG concentration | 6.77e-04 | 133 | 2 | 2 | HP:0004315 | |
| HumanPheno | Nephrotic syndrome | 7.39e-04 | 139 | 2 | 2 | HP:0000100 | |
| HumanPheno | Abnormal circulating IgG concentration | 8.73e-04 | 151 | 2 | 2 | HP:0410242 | |
| HumanPheno | Leukocytosis | 9.68e-04 | 159 | 2 | 2 | HP:0001974 | |
| HumanPheno | Gastrointestinal inflammation | 1.03e-03 | 164 | 2 | 2 | HP:0004386 | |
| HumanPheno | Hemolytic anemia | 1.07e-03 | 167 | 2 | 2 | HP:0001878 | |
| HumanPheno | Anemia due to reduced life span of red cells | 1.11e-03 | 170 | 2 | 2 | HP:0011895 | |
| HumanPheno | Glomerulopathy | 1.13e-03 | 172 | 2 | 2 | HP:0100820 | |
| HumanPheno | Skin rash | 1.13e-03 | 172 | 2 | 2 | HP:0000988 | |
| HumanPheno | Decreased circulating antibody concentration | 1.93e-03 | 224 | 2 | 2 | HP:0004313 | |
| HumanPheno | Recurrent upper respiratory tract infections | 2.16e-03 | 237 | 2 | 2 | HP:0002788 | |
| HumanPheno | Abnormal nasopharynx morphology | 2.38e-03 | 249 | 2 | 2 | HP:0001739 | |
| HumanPheno | Abnormal pharynx morphology | 2.60e-03 | 260 | 2 | 2 | HP:0033151 | |
| HumanPheno | Abnormal granulocyte count | 2.84e-03 | 272 | 2 | 2 | HP:0032309 | |
| HumanPheno | Abnormal renal glomerulus morphology | 3.08e-03 | 283 | 2 | 2 | HP:0000095 | |
| HumanPheno | Abnormal renal corpuscle morphology | 3.08e-03 | 283 | 2 | 2 | HP:0031263 | |
| HumanPheno | Recurrent lower respiratory tract infections | 3.19e-03 | 288 | 2 | 2 | HP:0002783 | |
| HumanPheno | Immunoglobulin abnormality | 3.34e-03 | 295 | 2 | 2 | HP:0100032 | |
| HumanPheno | Abnormal circulating immunoglobulin concentration | 3.34e-03 | 295 | 2 | 2 | HP:0010701 | |
| HumanPheno | Abnormality of B cell physiology | 3.37e-03 | 296 | 2 | 2 | HP:0005372 | |
| HumanPheno | Pneumonia | 3.72e-03 | 311 | 2 | 2 | HP:0002090 | |
| HumanPheno | Abnormal granulocyte morphology | 3.86e-03 | 317 | 2 | 2 | HP:0001911 | |
| HumanPheno | Abnormality of the pharynx | 3.93e-03 | 320 | 2 | 2 | HP:0000600 | |
| HumanPheno | Abnormal renal cortex morphology | 3.93e-03 | 320 | 2 | 2 | HP:0011035 | |
| HumanPheno | Abnormal lymphocyte physiology | 4.13e-03 | 328 | 2 | 2 | HP:0031409 | |
| HumanPheno | Abnormal leukocyte physiology | 4.13e-03 | 328 | 2 | 2 | HP:0033796 | |
| HumanPheno | Autoimmunity | 4.21e-03 | 331 | 2 | 2 | HP:0002960 | |
| HumanPheno | Abnormal myeloid leukocyte morphology | 4.60e-03 | 346 | 2 | 2 | HP:0010974 | |
| HumanPheno | Abnormality of humoral immunity | 4.71e-03 | 350 | 2 | 2 | HP:0005368 | |
| HumanPheno | Abnormal immunological laboratory finding | 4.87e-03 | 356 | 2 | 2 | HP:0003346 | |
| HumanPheno | Abnormal B cell morphology | 5.18e-03 | 367 | 2 | 2 | HP:0002846 | |
| HumanPheno | Abnormal oral mucosa morphology | 5.58e-03 | 381 | 2 | 2 | HP:0011830 | |
| HumanPheno | Diarrhea | 7.14e-03 | 431 | 2 | 2 | HP:0002014 | |
| HumanPheno | Abnormal nephron morphology | 7.82e-03 | 451 | 2 | 2 | HP:0012575 | |
| HumanPheno | Thrombocytopenia | 8.17e-03 | 461 | 2 | 2 | HP:0001873 | |
| HumanPheno | Abnormal platelet count | 9.27e-03 | 491 | 2 | 2 | HP:0011873 | |
| HumanPheno | Abnormal platelet morphology | 9.43e-03 | 495 | 2 | 2 | HP:0011875 | |
| HumanPheno | Splenomegaly | 9.46e-03 | 496 | 2 | 2 | HP:0001744 | |
| HumanPheno | Abnormal hematological laboratory findings | 1.04e-02 | 520 | 2 | 2 | HP:0003135 | |
| HumanPheno | Inflammatory abnormality of the skin | 1.04e-02 | 521 | 2 | 2 | HP:0011123 | |
| HumanPheno | Abnormal lymphocyte morphology | 1.06e-02 | 524 | 2 | 2 | HP:0004332 | |
| HumanPheno | Abnormal leukocyte count | 1.09e-02 | 532 | 2 | 2 | HP:0011893 | |
| HumanPheno | Abnormality of skin physiology | 1.35e-02 | 593 | 2 | 2 | HP:0011122 | |
| HumanPheno | Abnormal large intestine morphology | 1.36e-02 | 594 | 2 | 2 | HP:0002250 | |
| HumanPheno | Abnormal spleen morphology | 1.45e-02 | 613 | 2 | 2 | HP:0025408 | |
| MousePheno | abnormal thymus cell ratio | 9.56e-05 | 19 | 11 | 2 | MP:0008827 | |
| Domain | Aldo/ket_red/Kv-b | 8.13e-05 | 17 | 15 | 2 | IPR001395 | |
| Domain | NADP_OxRdtase_dom | 8.13e-05 | 17 | 15 | 2 | IPR023210 | |
| Domain | Aldo_ket_red | 8.13e-05 | 17 | 15 | 2 | PF00248 | |
| Domain | GPCR_Rhodpsn_7TM | 1.63e-03 | 670 | 15 | 4 | IPR017452 | |
| Domain | 7tm_1 | 1.70e-03 | 677 | 15 | 4 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 1.77e-03 | 685 | 15 | 4 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 1.83e-03 | 691 | 15 | 4 | PS50262 | |
| Domain | GPCR_Rhodpsn | 1.84e-03 | 692 | 15 | 4 | IPR000276 | |
| Domain | PH | 2.04e-02 | 278 | 15 | 2 | SM00233 | |
| Domain | PH_DOMAIN | 2.05e-02 | 279 | 15 | 2 | PS50003 | |
| Domain | PH_domain | 2.07e-02 | 280 | 15 | 2 | IPR001849 | |
| Pathway | WP_AFLATOXIN_B1_METABOLISM | 1.37e-05 | 6 | 14 | 2 | MM15846 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 9.78e-05 | 260 | 14 | 4 | M39397 | |
| Pathway | REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION | 1.55e-04 | 19 | 14 | 2 | M27449 | |
| Pathway | REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION | 2.94e-04 | 26 | 14 | 2 | MM15190 | |
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 12071861 | ||
| Pubmed | Mouse aldo-keto reductase AKR7A5 protects V79 cells against 4-hydroxynonenal-induced apoptosis. | 5.21e-07 | 3 | 15 | 2 | 16919859 | |
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 22863590 | ||
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 24590062 | ||
| Pubmed | 5.21e-07 | 3 | 15 | 2 | 39365156 | ||
| Pubmed | Characterisation of a novel mouse liver aldo-keto reductase AKR7A5. | 5.21e-07 | 3 | 15 | 2 | 12123834 | |
| Pubmed | 1.04e-06 | 4 | 15 | 2 | 12879023 | ||
| Pubmed | The mouse Rhl1 and Rhag genes: sequence, organization, expression, and chromosomal mapping. | 1.14e-05 | 12 | 15 | 2 | 10495887 | |
| Pubmed | 1.82e-05 | 15 | 15 | 2 | 9700202 | ||
| Pubmed | SUMOylation of DDX39A Alters Binding and Export of Antiviral Transcripts to Control Innate Immunity. | 3.01e-05 | 915 | 15 | 5 | 32393512 | |
| Pubmed | Four paralogous protein 4.1 genes map to distinct chromosomes in mouse and human. | 3.28e-05 | 20 | 15 | 2 | 9828140 | |
| Pubmed | 1.55e-04 | 249 | 15 | 3 | 9371744 | ||
| Interaction | PLEKHB1 interactions | 3.24e-06 | 40 | 15 | 3 | int:PLEKHB1 | |
| Interaction | AKR7A3 interactions | 6.99e-05 | 17 | 15 | 2 | int:AKR7A3 | |
| Interaction | CYP51A1 interactions | 1.23e-04 | 134 | 15 | 3 | int:CYP51A1 | |
| Interaction | ABHD6 interactions | 1.80e-04 | 27 | 15 | 2 | int:ABHD6 | |
| Cytoband | 19p13.1 | 1.11e-04 | 48 | 15 | 2 | 19p13.1 | |
| Cytoband | 1p36.13 | 1.52e-04 | 56 | 15 | 2 | 1p36.13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 2.03e-03 | 797 | 15 | 3 | chr19p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 2.03e-02 | 681 | 15 | 2 | chr1p36 | |
| GeneFamily | Olfactory receptors, family 10 | 7.07e-04 | 66 | 11 | 2 | 157 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPERMETHYLATED_AND_DN | 6.38e-05 | 21 | 15 | 2 | M45036 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_EPITHELIAL_CELL_AGEING | 8.38e-05 | 24 | 15 | 2 | MM3723 | |
| ToppCell | LV-11._Adipocyte|World / Chamber and Cluster_Paper | 2.17e-05 | 166 | 15 | 3 | 7e5852891714465c6228c9f955fd511ec79d0e02 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.21e-05 | 167 | 15 | 3 | 063ec29b32e40aaa138a691da3a79ee8eef0c2be | |
| ToppCell | LV-11._Adipocyte|LV / Chamber and Cluster_Paper | 2.46e-05 | 173 | 15 | 3 | c2d3fcb3de71015d03d14c63450853d2b03ffa71 | |
| ToppCell | facs-Skin-Telogen-3m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 176 | 15 | 3 | 9c0fb2c6ae84febdf7c3d4e648985f597dcffe7a | |
| ToppCell | facs-Skin-Telogen-3m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 176 | 15 | 3 | 3d372c1d527fcc118d1e5809f2524fc387682472 | |
| ToppCell | facs-Skin-Telogen-3m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 176 | 15 | 3 | 7b3f3d9b33770edf294cee0eccaf8a46f9331461 | |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | 2.63e-05 | 177 | 15 | 3 | f0edf04930692418953e4f00a917257804ec0ffd | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 2.68e-05 | 178 | 15 | 3 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | LA-11._Adipocyte|World / Chamber and Cluster_Paper | 2.91e-05 | 183 | 15 | 3 | b177be283e1553fb1f69a346f1ba79ad00297fa2 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 2.91e-05 | 183 | 15 | 3 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.95e-05 | 184 | 15 | 3 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | droplet-Skin-nan-21m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 187 | 15 | 3 | 38d7b19fde6811f5fbf548b2464486b197476dc6 | |
| ToppCell | droplet-Skin-nan-21m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 187 | 15 | 3 | ea33a5bd60b7f5f6d5b07a7f06a5a56395943641 | |
| ToppCell | droplet-Skin-nan-21m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 187 | 15 | 3 | 1dbc2c0ab85033e5de776bbfdb73ebd3a50d2cc6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.91e-04 | 88 | 15 | 2 | c816c711ff5781ca7fab8ba987243b326bc85b22 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-04 | 100 | 15 | 2 | 97ca9cda55a05fbb4d1f5d61f847c965e014f05c | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-2|TCGA-Bladder / Sample_Type by Project: Shred V9 | 6.20e-04 | 111 | 15 | 2 | aeb2c06beda62f9a79fc73788dd1c5cf9a2f35fe | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.00e-04 | 118 | 15 | 2 | 3cebd17f4688cd43fe1283dc60957e87d5536810 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.00e-04 | 118 | 15 | 2 | 61b00b001edb1954a5fffaf4dfe71708124a45e5 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.00e-04 | 118 | 15 | 2 | 71f63efc641cd07c870f7695118fb244929c1536 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.23e-04 | 128 | 15 | 2 | e100629f6038e32176ffcc81bd06bd175df46cef | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.88e-04 | 133 | 15 | 2 | 81189e8516a431d5890a0909f9fc7c82ec3442bc | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-8|TCGA-Lung / Sample_Type by Project: Shred V9 | 9.42e-04 | 137 | 15 | 2 | 05ca83c30e3dbe74c81278b3636d57da2c20b458 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Mast-Mast_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-03 | 146 | 15 | 2 | a5c84ad44d6ffb25028a4fd5454fd5de81b16a5e | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Mast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-03 | 146 | 15 | 2 | 8133037881c15e75637fc616091a7055488dd5fc | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Esophageal_Carcinoma-Adenocarcinoma-3|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.07e-03 | 146 | 15 | 2 | e55b4acecf4e363b5afa287c747c2e58c4597f3a | |
| ToppCell | COVID-19_Moderate-multiplets|COVID-19_Moderate / disease group, cell group and cell class | 1.08e-03 | 147 | 15 | 2 | baf15c773d7751bc6f64d4974a22738626f2b3ff | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-03 | 148 | 15 | 2 | 7cb4865a1e9522e24f9c14799568b67172bd99dc | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Esophageal_Carcinoma-Adenocarcinoma|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.11e-03 | 149 | 15 | 2 | 92a8931a51db619fb5f0638d319c02e7838f6559 | |
| ToppCell | E16.5-samps-Myeloid-Fetal_macrophage-macrophage_-_intermediate_-_unactivated|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.13e-03 | 150 | 15 | 2 | 60fdd266aaca1b589b9a77465a4a7fad4921339a | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l14|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-03 | 152 | 15 | 2 | 0fda8980b10ce16179dea92301db74d728f41794 | |
| ToppCell | NS-moderate-d_0-4-Myeloid-Monocyte-derived_DC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.16e-03 | 152 | 15 | 2 | ce944f7c1444fd0cb793db183b96818e37342b24 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-03 | 155 | 15 | 2 | 7aba8ef53c9170ad8ed955c904c8991097ab1e32 | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 1.22e-03 | 156 | 15 | 2 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | COVID-19-APC-like-Alveolar_macrophages|COVID-19 / group, cell type (main and fine annotations) | 1.22e-03 | 156 | 15 | 2 | 735ade77cfa16b9386a0c7ec2bd14bd2e78a51ad | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-03 | 157 | 15 | 2 | c762b03e254c73222094725ca8ac1c8eb428bccb | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-03 | 157 | 15 | 2 | 6b5b08bb5520fcf6f4c0560f7ed7645ec179806d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-03 | 157 | 15 | 2 | a633fb8e7a009490c6002bf272eceaf317f27af6 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-03 | 157 | 15 | 2 | 7fdc0094dd5729990a91a30c1982a14c74650b52 | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-03 | 158 | 15 | 2 | 91d8c93af328c3bbebe1d8f019b94849ebc548c0 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.25e-03 | 158 | 15 | 2 | d78e7e52657dc094430291fec07e9c298be9e584 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.26e-03 | 159 | 15 | 2 | 2233fee5dcdb6c7dee5b1bd8efbc07d86b339927 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma-7|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.26e-03 | 159 | 15 | 2 | 75a82bbabd97b168dbf1c3f43a9bdad48ce18c78 | |
| ToppCell | Control-Myeloid-Monocytes,_Macrophages-Mast-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.26e-03 | 159 | 15 | 2 | 81782e9e370558d61af5e0c760ac9759d69fb725 | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-CD45____NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-03 | 160 | 15 | 2 | 12aaab0291035f578e2433efd169ae72f393a5a5 | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-03 | 160 | 15 | 2 | 398f162e8a75c6cb5c3e4d1832e98d386e1f222b | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-03 | 161 | 15 | 2 | 334f540dff3508d451e5e85e8e4e8f3b8d6b74e7 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-03 | 161 | 15 | 2 | ae1cee34361dde9964581cca99a29578c3b3bd99 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-03 | 161 | 15 | 2 | 33de3e8b3238fcfc66dfbf89a913a07d464d6c35 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-03 | 161 | 15 | 2 | 81d44438e4be4e68a59247e62f02026301a8a0c5 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-03 | 165 | 15 | 2 | ba041deb0d9c187f251493ccd4794b5f09abd5aa | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-03 | 165 | 15 | 2 | 8c7a6f9e2ca0ce077426d3d0726e3f5a4c03b296 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-03 | 166 | 15 | 2 | c22b0f3bf990d94b615a3aacee5de548da2db628 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-03 | 166 | 15 | 2 | 0975fc165bcc7e85f053d9d0244fffe407c23571 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-03 | 166 | 15 | 2 | e4f14b2dd8c6199fa27cc3e3beeda681a3b5b889 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-MAIT-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.38e-03 | 166 | 15 | 2 | bb93db4613c067c56614ab1ca39e73ee46484387 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD8+_T-MAIT|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.38e-03 | 166 | 15 | 2 | c1f17a028bb27b8f202bcfffa7de7373b1cdd990 | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-03 | 168 | 15 | 2 | 794035cb63353a7d02fd9939deb5b4d075c9d95a | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.41e-03 | 168 | 15 | 2 | 2765d98f0b7f6861d662937535e051d41dba3500 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium-7|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.41e-03 | 168 | 15 | 2 | a97e8e07ba949b30805aeed5f60fa5e092b9d3d4 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-Basophil/Mast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.41e-03 | 168 | 15 | 2 | 34722e14f28313f2e4644b3c1861ef12958cee9f | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.41e-03 | 168 | 15 | 2 | 0e99ecd94ab8e5372e30433d7d0aa76b4d54257a | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-03 | 168 | 15 | 2 | 3bddf411a60137a8883fc9e77586e4719b0d6067 | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-03 | 168 | 15 | 2 | 6fddc957a0503455d8c165862b5eb8e5fdb8a510 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-03 | 168 | 15 | 2 | b6d948857ee652351ddbe383b75fdd1721cd8721 | |
| ToppCell | droplet-Fat-Bat-18m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-03 | 168 | 15 | 2 | 1e23b634f96e88b976a523ca1f3fc08f6fe9b239 | |
| ToppCell | metastatic_Brain-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 1.41e-03 | 168 | 15 | 2 | 4bf3f85aac4b335efa93d22c9ce7b153cb5ce152 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-03 | 169 | 15 | 2 | 2de213b083f57f47be58427c0ce127fee9f85caa | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-03 | 169 | 15 | 2 | da607c1d068038d5a3d1117f6aa6e4c6f3552e97 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 1.43e-03 | 169 | 15 | 2 | 241644823e6f949aaf4c671d4579721d7ef6b0e5 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-03 | 169 | 15 | 2 | f2e20049a17eee533d49bd5f24a51962d123d132 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-03 | 169 | 15 | 2 | 4c6892551e9dec94fc62b3beab1e6d424639a1e9 | |
| ToppCell | COVID-19-Heart-Adipocyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.43e-03 | 169 | 15 | 2 | bd39f85b48207955f80ca120a11e15a0124117b9 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-03 | 169 | 15 | 2 | a14b46231e079a0fd9f3ca13d5d48113be76fd0f | |
| ToppCell | CV-Mild-7|CV / Virus stimulation, Condition and Cluster | 1.44e-03 | 170 | 15 | 2 | 25ebde7d2f8ae1afdfaf5876284ff20bb179eb10 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-03 | 170 | 15 | 2 | 3ad9f950b87ee98f025ab9b4a8ed551e6a9b4764 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.44e-03 | 170 | 15 | 2 | d682178d11d67eb5a02d0c6b3967645e37bcc62a | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.44e-03 | 170 | 15 | 2 | 516b38c4ecf6b0b04c5d4f80c510dcc00b328c6f | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.44e-03 | 170 | 15 | 2 | cdc19013da7c41d1ed8400a6a643e4c684ff9912 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.44e-03 | 170 | 15 | 2 | 0bde0a40440c7fdf7ba89cac8831d4014e7a4807 | |
| ToppCell | severe-Myeloid-Eosinophils|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.44e-03 | 170 | 15 | 2 | 863f0266d5837cdbc3e09a3fe6a99dd3e6261674 | |
| ToppCell | control-Myeloid-Eosinophils|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.46e-03 | 171 | 15 | 2 | 82f736c33ed96c0865618e8f8eb82a5487126bdc | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-03 | 171 | 15 | 2 | 2e7cc311005958af52f39ca6c310c85b43a85aaf | |
| ToppCell | normal_Lung-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass | 1.46e-03 | 171 | 15 | 2 | f49dfe11ae66d82125b577c48345a13683d7bb7b | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-03 | 171 | 15 | 2 | 4b599f953c8e5b947b2c8bbbf7fe6f9dc388e336 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.46e-03 | 171 | 15 | 2 | 1af575809b3334bfaa019ff26c56e6cb03c82ee8 | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-03 | 171 | 15 | 2 | 872b3b33cd3893d63c45617db0269692430b0e8b | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-03 | 172 | 15 | 2 | 7af0713c40ea48f1e92c859c4fc4d8f0137c4415 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-03 | 172 | 15 | 2 | c05af6e559f6af0fb15cefa03ffa1413e98a1a4a | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-03 | 172 | 15 | 2 | b3c53fd7e50f36de6a8585ae21d04e17932f262c | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Basophil|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-03 | 172 | 15 | 2 | 953b05f776348cff784e79c93df65841939d880f | |
| ToppCell | control-Myeloid-Mast_cell|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.48e-03 | 172 | 15 | 2 | c1c99e6732234a6649a79610e99390db0c8f19b0 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-03 | 172 | 15 | 2 | 1b133be191252e7053faeacf9547730c3ae28d21 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell-Ly6g5b+_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-03 | 173 | 15 | 2 | 0a355386210a13927ea29b10b64cb059459952d4 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Basophil|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-03 | 173 | 15 | 2 | 8ca650542655c27516029e5bace97ff1b9dcc256 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-03 | 173 | 15 | 2 | 53e97835d7a518c278e7b90a0734eb0095d6aa33 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-Basophil/Mast_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-03 | 173 | 15 | 2 | 117163c5cd2b7aaa1c0682c8ac44b4249df4d2f8 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-03 | 173 | 15 | 2 | 4f849d236ee358ad30ac977745ac43c8e9778e94 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-03 | 173 | 15 | 2 | 39c3b8313354c4c60764597507a2505dcfa4e8c7 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-03 | 173 | 15 | 2 | 3678b300cad4effd7f49bfb043305ed512693848 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PSMTSAALRWMYHHS | 261 | Q8NHP1 | |
| PSMTSATLRWMYHHS | 261 | O95154 | |
| WMMSSSLPHVTSNHV | 651 | Q9UK96 | |
| WPYSSHRMRFITNHS | 16 | Q9UPC5 | |
| YGMATSHSWEMPSSD | 61 | Q9ULX6 | |
| MATVWSERSLHTPMY | 46 | O60403 | |
| APHWYASHMKTRATR | 161 | P43115 | |
| MHSPWMSNTLHVFCA | 2041 | Q5JSL3 | |
| WSSMTPHSHSRTPEY | 166 | P08519 | |
| WSSMTPHSHSRTPEY | 736 | P08519 | |
| SHMPMWSARLLTRAH | 46 | Q8N1N5 | |
| MATVWSERSLHTPMY | 46 | Q9Y4A9 | |
| MEWHSQMHSVTLHPS | 1021 | Q9P2F6 | |
| TAHERMPWYHSSLTR | 156 | P43403 | |
| WIHLYVMASAMSSSP | 6 | Q96PS6 | |
| SFHTAMGMAWSLHYQ | 21 | Q6ZSV7 | |
| HSMSTWMELYPAVST | 511 | Q6NWY9 | |
| MTPLMWAAYRTHSVD | 191 | Q8IUH5 | |
| FSWSSHLIAHMRMHT | 521 | Q8WXB4 |